NN106: Prospective Phase II Study of Cytochrome C Oxidase Activity as a Novel Biomarker In Subjects With Newly Diagnosed Primary Glioblastoma Multiforme

Project: Research project

Project Details

StatusFinished
Effective start/end date11/1/16 → 6/19/21

Funding

  • Massachusetts General Hospital (1 U01NS093663-01A1 // 1 U01NS093663-01A1)
  • National Institute of Neurological Disorders and Stroke (1 U01NS093663-01A1 // 1 U01NS093663-01A1)